Biotek-snakken — Marts 2023
-
Nogen der overvejer at deltage i Gubra´s IPO? "Samlet udbyder Gubra nye aktier for 500 mio. kr., hvoraf en række store kerneinvestorer allerede har indvilliget i at købe for 330 mio. kr. Aktierne udbydes til 110 kr. per styk., og udbuddet kan øges med ekstra 15 pct. til 575 mio. kr., hvis efterspørgslen er til det."
-
Mød dem her https://www.youtube.com/watch?v=Pey9pEFpuPs
-
Xbrane Biopharma AB: BioStock: Xbrane's CEO on the launch of Ximluci in Europe https://www.biostock.se/en/2023/03/xbranes-ceo-on-the-launch-of-ximluci-in-europe/
-
Evaxion presents a new source of AI-derived immunotherapeutic targets strongly associated with the overall survival of cancer patients https://investors.evaxion-biotech.com/news-releases/news-release-details/evaxion-presents-new-source-ai-derived-immunotherapeutic-targets
-
Pharma og biotek - opdatering fra debat og chat uge 12 Ambu ' Novo Nordisk ' Bavarian Nordic ' Zealand Pharma
Helge Larsen gennemgår det sidste nye om virksomhederne inden for pharma og biotek ud fra den kvalificerede debat og chat på ProInvestor. https://www.proinvestor.com/boards/111628
-
BioNTech årsregnskab https://investors.biontech.de/node/14871/pdf 243 mio aktier kurs 113 €, MCAP 27.5 mia. Cash 13,9 mia
-
Er der nogen her der følger Brain+? Det er en sørgelig kursudvikling på det sidste. Nogen høvler aktier ud hver eneste dag
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind